Zynex Inc (ZYXI) Reports 17% Revenue Growth in FY 2023, Announces New $20 Million Stock ...
Despite Revenue Uplift, Net Income and Adjusted EBITDA Experience Downturn
Stay updated with breaking news from Thomas Sandgaard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite Revenue Uplift, Net Income and Adjusted EBITDA Experience Downturn
Blues left-back Matt Penney has joined fellow League One side Charlton Athletic on loan for rest of the season.
ENGLEWOOD - Zynex, Inc. , an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient...
/PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...
Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, 2024, or when the $20.0 million limit is reached.